SNRNP27 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.274400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.616400E-01
Normal-vs-Stage2
8.841800E-01
Normal-vs-Stage3
5.750600E-01
Normal-vs-Stage4
2.469200E-01
Stage1-vs-Stage2
8.928800E-01
Stage1-vs-Stage3
5.502400E-01
Stage1-vs-Stage4
2.001200E-01
Stage2-vs-Stage3
5.036000E-01
Stage2-vs-Stage4
8.744200E-02
Stage3-vs-Stage4
1.432810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.465600E-01
Normal-vs-AfricanAmerican
9.500600E-01
Normal-vs-Asian
4.309000E-01
Caucasian-vs-AfricanAmerican
9.789800E-01
Caucasian-vs-Asian
1.735450E-01
AfricanAmerican-vs-Asian
4.468400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.475600E-01
Normal-vs-Female
9.754200E-01
Male-vs-Female
3.961200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.106000E-01
Normal-vs-Age(41-60Yrs)
5.837000E-01
Normal-vs-Age(61-80Yrs)
7.331000E-01
Normal-vs-Age(81-100Yrs)
4.317400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.033600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.309200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.180000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.444600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.279500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.058800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.712400E-01
Normal-vs-Daily Drinker
7.519200E-01
Normal-vs-Weekly Drinker
5.671000E-01
Normal-vs-Occasional Drinker
5.870600E-01
Normal-vs-Social Drinker
9.724000E-01
Non Drinker-vs-Daily Drinker
8.558800E-01
Non Drinker-vs-Weekly Drinker
6.787800E-01
Non Drinker-vs-Occasional Drinker
4.977800E-02
Non Drinker-vs-Social Drinker
4.449000E-01
Daily Drinker-vs-Weekly Drinker
6.027400E-01
Daily Drinker-vs-Occasional Drinker
1.004620E-01
Daily Drinker-vs-Social Drinker
5.840000E-01
Weekly Drinker-vs-Occasional Drinker
6.777900E-02
Weekly Drinker-vs-Social Drinker
3.193600E-01
Occasional Drinker-vs-Social Drinker
2.691200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.740380E-01
Normal-vs-Grade 2
1.350330E-02
Normal-vs-Grade 3
1.265750E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.186190E-01
Grade 1-vs-Grade 3
4.961600E-02
Grade 1-vs-Grade 4
1.740380E-01
Grade 2-vs-Grade 3
5.372000E-01
Grade 2-vs-Grade 4
1.350330E-02
Grade 3-vs-Grade 4
1.265750E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.757600E-01
Normal-vs-NonDiabetic
8.501800E-01
Diabetic-vs-NonDiabetic
7.281600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.427600E-01
Normal-vs-NoPancreatitis
8.591600E-01
Pancreatitis-vs-NoPancreatitis
9.076400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.365800E-01
Normal-vs-N1
9.251400E-01
N0-vs-N1
5.482400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.647200E-01
Normal-vs-TP53-NonMutant
7.420800E-01
TP53-Mutant-vs-TP53-NonMutant
9.095800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
